Paternally Inherited Phenotypes in Cholestasis
NCT03337074 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2019-08-02
Summary
For some years investigators have known that the health of fathers at the time their baby is conceived has an influence on the health of their child in the future. Many studies looking at this effect have investigated fathers with obesity and other metabolic disorders. These disorders can alter the risk of obesity and diabetes in the children of these men. More recently, studies have been undertaken to establish the mechanism by which this risk is inherited by the children. Studies of sperm have identified that changes in the structure and function of the sperm play a role.
Primary Sclerosing Cholangitis (PSC) and Primary Biliary Cholangitis (PBC) are included in a group of cholestatic liver disorders that are associated with elevated levels of bile acids in the blood (cholestasis). A previous study has established that children born to women who have cholestasis during pregnancy are at an increased risk of obesity later in life. Our study will investigate whether there is a similar effect on the health of children if their father has cholestasis.
The study has 2 arms, the Sperm Epigenome arm and the Outcomes arm.
In the Sperm Epigenome arm of the study, the structure and function of sperm from men with PSC, PBC and other cholestatic liver disorders will be investigated and compared to the structure and function of sperm from healthy men.
In the Outcomes arm of the study, basic health parameters of fathers who had PSC, PBC or another cholestatic liver disease either before or after their child was conceived will be studied. Basic health parameters will also be studied in their child when the child is between 16 and 25 years of age.
Conditions
- Cholestasis
- Primary Sclerosing Cholangitis
- Primary Biliary Cirrhosis
Interventions
- OTHER
-
Questionnaire, semen sample, fasting blood sample
Participants are asked to complete a questionnaire and provide a semen sample and fasting blood sample.
- OTHER
-
Questionnaire
Participants are asked to complete a questionnaire.
- OTHER
-
Questionnaire, fasting blood sample
Participants are asked to complete a questionnaire and provide a fasting blood sample.
Sponsors & Collaborators
-
King's College Hospital NHS Trust
collaborator OTHER -
Guy's and St Thomas' NHS Foundation Trust
lead OTHER
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-02-08
- Primary Completion
- 2020-04-30
- Completion
- 2020-04-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid
NCT00007020 ·Status: COMPLETED ·Phase: PHASE3
-
Quantitative Liver Function Tests Using Cholates
NCT01907074 ·Status: TERMINATED ·Phase: PHASE2
-
Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders
NCT01373918 ·Status: TERMINATED ·Phase: PHASE4
-
Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency
NCT00006061 ·Status: COMPLETED ·Phase: NA
-
Intralumenal Effects on Cholesterol Absorption/Synthesis
NCT00328211 ·Status: COMPLETED ·Phase: NA
-
Osmotic Fragility in Red Blood Cells of Pediatric Patients With Cholestatic Liver Disease
NCT05582447 ·Status: ACTIVE_NOT_RECRUITING
-
Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis
NCT01865812 ·Status: COMPLETED ·Phase: PHASE2
-
Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Subjects
NCT04053023 ·Status: COMPLETED ·Phase: PHASE1
-
SMOFlipid to Lessen the Severity of Neonatal Cholestasis
NCT02721277 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Impact of Foods on Bile Acids, Metabolites, and Inflammation
NCT05245357 ·Status: UNKNOWN ·Phase: NA
-
Intestinal Microbiome Composition in Infants With Biliary Atresia (BA)
NCT03890536 ·Status: WITHDRAWN
-
Pharmacotoxicology of Trichloroethylene Metabolites
NCT00874276 ·Status: COMPLETED ·Phase: NA
-
Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
NCT02357576 ·Status: COMPLETED ·Phase: PHASE3
-
Expression of BCRP in Icteric Patients
NCT00295360 ·Status: COMPLETED
-
Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease
NCT00007033 ·Status: COMPLETED ·Phase: NA
-
Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)
NCT00570765 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT
NCT03253276 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
BSEP Function Rescue During Childhood Inhereditary Cholestatic Diseases
NCT04531878 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Bile Acids As Determinants of Postprandial Metabolism
NCT06758453 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT
NCT01879735 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis
NCT01473524 ·Status: COMPLETED ·Phase: PHASE3
-
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
NCT04634643 ·Status: RECRUITING
-
Cholestasis Prevention: Efficacy of IV Fish Oil
NCT00512629 ·Status: COMPLETED ·Phase: PHASE1
-
Obeticholic Acid in Bariatric and Gallstone Disease
NCT01625026 ·Status: COMPLETED ·Phase: PHASE2
-
Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic Fibrosis
NCT03312140 ·Status: COMPLETED ·Phase: NA